Dotzenrath C, Goretzki P E, Farnebo F, Teh B T, Weber G, Röher H D, Larsson C
Department of Surgery, Heinrich-Heine University, Düsseldorf, Germany.
Exp Clin Endocrinol Diabetes. 1996;104 Suppl 4:105-7. doi: 10.1055/s-0029-1211714.
Hyperparathyroidism (HPT) can be caused by solitary parathyroid adenomas and carcinomas, and primary and secondary multiglandular parathyroid disease. Primary HPT is also a feature of several hereditary diseases e.g. multiple endocrine neoplasia type 1 and type 2A (MEN1 and 2A), familial hypocalciuric hyperparathyroidism (FHH), the HPT-jaw tumor syndrome (HPT-JT), and familial isolated HPT. Summarizing data from the literature and our own observations, various genetic abnormalities are observed in the pathogenesis of HPT. These include chromosomal deletions of the MEN1 locus on 11q in sporadic and MEN1 associated primary HPT, of RB1 on 13q in carcinomas, and of the FHH gene located on 3q in sporadic primary and secondary HPT. Genetic material is also lost from chromosomes 1p, 6q, 15q and X suggesting loss of yet unidentified tumor suppressor genes in these regions. In addition the HRPT2 gene on 1q, as well as the proto-oncogenes RET on 10q and PRAD1 on 11q are associated with a subset of parathyroid tumors.
甲状旁腺功能亢进症(HPT)可由孤立性甲状旁腺腺瘤和癌以及原发性和继发性多腺体甲状旁腺疾病引起。原发性HPT也是几种遗传性疾病的特征,例如1型和2A型多发性内分泌腺瘤病(MEN1和2A)、家族性低钙血症性高钙血症(FHH)、HPT-颌骨肿瘤综合征(HPT-JT)以及家族性孤立性HPT。综合文献数据和我们自己的观察结果,在HPT的发病机制中观察到了各种基因异常。这些包括散发性和MEN1相关原发性HPT中11q上MEN1基因座的染色体缺失、癌中13q上RB1的缺失,以及散发性原发性和继发性HPT中3q上FHH基因的缺失。1p、6q、15q和X染色体上的遗传物质也有丢失,提示这些区域存在尚未确定的肿瘤抑制基因的缺失。此外,1q上的HRPT2基因以及10q上的原癌基因RET和11q上的PRAD1与一部分甲状旁腺肿瘤有关。